Voloridge Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-498,631
Closed -$3.58M 1203
2025
Q4
$3.58M Sell
498,631
-3,331
-0.7% -$26.3K 0.01% 825
2025
Q3
$5.36M Buy
501,962
+333,148
+197% +$3.27M 0.02% 727
2025
Q2
$1.63M Buy
+168,814
New +$1.74M 0.01% 979
2025
Q1
Sell
-118,850
Closed -$1.77M 1315
2024
Q4
$1.77M Sell
118,850
-431,143
-78% -$7.03M 0.01% 956
2024
Q3
$10.5M Buy
549,993
+455,511
+482% +$9.44M 0.04% 571
2024
Q2
$1.96M Sell
94,482
-311,943
-77% -$6.2M 0.01% 948
2024
Q1
$7.64M Buy
+406,425
New +$6.97M 0.03% 550

Other funds holding OGN

Voloridge Investment Management's OGN Position: Q1 2026 in Review

Voloridge Investment Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 498,631 shares — an estimated $3.58M sold.

Voloridge Investment Management first reported a position in OGN in Q1 2024 and held it in 7 quarters. The position peaked at $10.5M in Q3 2024. 607 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Voloridge Investment Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 498,631 Organon & Co shares in Q1 2026, an estimated $3.58M.
  • Voloridge Investment Management first reported a position in Organon & Co in Q1 2024 and held it in 7 quarters.
  • Voloridge Investment Management's Organon & Co position peaked at $10.5M in Q3 2024.
  • 607 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.